The evaluation of oestrogen receptors (ER) and progesterone receptors (PR) in breast cancer is commonly based on a cut-off value of 10fmolmg-1 protein, which separates receptor-negative from receptor-positive tumours. However, not all investigators adopt this value. The labelling index (LI), which estimates the percent S-phase cells after tritiated thymidine incorporation, has been recognized as a powerful predictive factor in breast cancer and in other tumours (Courdi & Malaise, 1986 (Gioanni et al., 1979) . The median value of ER was 35 fmol mg-1 with a range of 0 and 1,040. Levels higher than 10 fmol mg-1 were observed in 117 cases (72%). PR were measured in 142 cases. The median value was 45 fmol mg-1 (range: 0-2,350). Levels higher than 10 fmol mg-1 were encountered in 111 (78%) cases.
The LI was measured in all patients. It was determined by a technique previously described (Gioanni et al., 1979 greater than it. The x2 with one degree of freedom was calculated with the corresponding P value. The cut-off level was then changed and survival of these newly formed groups was compared and another x2 was computed. This procedure was applied to ER, PR and LI in breast cancer patients, and to LI in head and neck cancer patients. Figure 1 illustrates the dependence of x2 for survival on the cut-off value of hormone receptors in breast cancer. A cut-off of 10 fmol mg -1 for either ER or PR did not distinguish between groups having different prognosis since the points were below the significance level (P = 0.05 for X2= 3.84). The highest x2 was observed at an ER cut-off of 20 fmol mg-1 (X2 = 5.13). For PR, the best discriminant cutoff was 45 fmol mg -1, which was the median value, pointed out by the right arrow (X2 = 11.04).
The influence of the cut-off value of the LI is shown in Figure 2 . The best discriminant value in breast cancer was close to the median value. However, in head and neck cancer, the median LI failed to separate between 2 groups having different prognosis. Higher cut-off values allowed a distinction between a small group of patients with poor survival and a bigger number of patients with a significantly better survival.
These findings raise the question about the way of dealing with continuous variables if they are intended to influence prognosis. Since many tests have been applied to the same population, the reported x2 and the corresponding P value have to be treated with caution. Indeed, multiple tests carry the risk of increasing the probability of finding statistically significant differences which are due to chance. If they are to be done, the P values should be adjusted accordingly. It would have been more appropriate in that case to use the x2 table with 2 degrees of freedom (R. Peto, personal communication). This would raise the horizontal lines of significance (Figures 1 and 2) , for instance by plotting the P=0.05 level at x2 = 5.99 instead of 3.84. This procedure would have only changed the significance values, but not the shape of the curves. However, the aim of this report was not to determine the exact significance of a certain cut-off level, but rather to investigate the relative impact of the cut-off value on the end-point. Many methods have been described for hormone receptor assays (Jensen et al., 1971 ; EORTC breast cancer cooperative group, 1973; Meyer et al., 1978; Wagner, 1978; Wrange et al., 1978) . Moreover, there exists a wide variation in results among laboratories using the same method (Borjesson et al., 1987) . There is a convention using 10 fmol mg-' cytosol protein to separate between ER-negative and ERpositive tumours (McGuire et al., 1975) , although many institutions use lower (Stewart et al., 1982; Hartveit et al., 1983; Mason et al., 1983; Howat et al., 1985; Bonneterre et al., 1988) or sometimes higher (Vollenweider-Zerargui et al., 1986) values. There is greater assay variability for PR (Jordan et al., 1983) and here again the cut-off values are variable. The median PR level may be as low as 5 fmol mg- (Clarke & McGuire, 1983) , or as high as 50 fmol mg-1 (Bonichon et al., 1988) . These great variations cannot be explained solely by differences in the characteristics of the patient populations. Values up to 800fmolmg-1 have been considered as PR-low tumours (Sutton et al., 1987) . Vollenweider-Zerargui et al. (1986) varied systematically the limits of positivity and negativity to obtain the best predictive cut-off. Forrest et al. (1980) have also observed that moving the cut-off value of ER can affect its prognostic effect. The great variability of institutions in fixing the threshold of positivity has been recently reviewed (Namer, 1988) .
In our study, levels higher than 10 fmol mg-I for both ER and PR are needed to distinguish between good and bad prognosis patients. In fact, no patient having tumour PR higher than 45fmolmg-1 died during the follow-up period.
Variations in LI values seem less marked among institutions. Our median LI values in breast cancer as well as in head and neck cancer are close to those of others (Gentili et al., 1981; Silvestrini et al., 1984) . Yet, in breast cancer, the median LI seems to be an adequate cut-off to distinguish between two groups of patients with different outcome. The fact that most investigators use median LI may explain why LI is actually a well recognized prognostic factor in breast cancer (Meyer et al., 1984; Tubiana et al., 1984; Silvestrini et al., 1986; H6ry et al., 1987) . Similar results have been observed with the percent S-phase fraction as measured by flow cytometry (Dressler et al., 1988) . These investigators have undertaken cut-off searching studies in their series, looking for the optimum value (Dressler & McGuire, personal communication) .
The few studies which have addressed the role of the proportion of S-phase cells on prognosis in head and neck cancer have reached no clear-cut conclusions (Courdi et al., 1980; Silvestrini et al., 1984; Muller et al., 1985) . This work suggests that a higher than median cut-off is more optimal for predicting outcome. In lung cancer, Volm et al. (1985) have found that a LI cut-off higher than median adverscly affects survival. In a recent review, we have observed that the percent S-phase cells is of prognostic significance in 60% of the reported investigations (Courdi & Malaise, 1986) . Failure to detect a link with prognosis may be due to lack of cut-off searching studies. The reason why the same variable needs to have different cut-off values according to the tumour type is unknown and deserves further investigation. The way the LI influences survival in this study suggests that it is not necessary to have equal-sized populations on each side of the cut-off level (by using median values) in order to get out maximum significance.
Finally, it is hoped that these findings would draw attention to the fact that arbitrarily taken values to discriminate between low and high levels of continuous variables may not be suitable for the classification of patients into low and high risk groups. We therefore agree with VollenweiderZerargui et al. (1986) in suggesting that each laboratory should establish adequate cut-off values of these and other continuous variables in order to achieve the best clinical correlation.
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